XML 12 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (UNAUDITED) - USD ($)
$ in Thousands
Total
Common stock warrants
Additional Paid-in Capital [Member]
Accumulated other comprehensive loss
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ 228,442 $ 5 $ 688,124 $ (87) $ (459,600)
Beginning balance, Shares at Dec. 31, 2023   52,388,961      
Share-based compensation 5,261   5,261    
Issuance of common stock upon exercise of stock options 39   39    
Issuance of common stock upon exercise of stock options, Shares   28,227      
Issuance of common stock upon release of restricted stock units, Shares   423,869      
Shares withheld for the withholding tax on vesting of restricted stock (55)   (55)    
Shares withheld for the withholding tax on vesting of restricted stock, Shares   (25,286)      
Unrealized loss on available-for-sale securities (161)     (161)  
Net Income (Loss) (35,326)       (35,326)
Ending balance at Mar. 31, 2024 198,200 $ 5 693,369 (248) (494,926)
Ending balance, Shares at Mar. 31, 2024   52,815,771      
Beginning balance at Dec. 31, 2024 99,352 $ 6 711,160 47 (611,861)
Beginning balance, Shares at Dec. 31, 2024   54,139,560      
Share-based compensation $ 4,564   4,564    
Issuance of common stock upon exercise of stock options, Shares 273 273      
Issuance of common stock upon release of restricted stock units, Shares   857,209      
Shares withheld for the withholding tax on vesting of restricted stock $ (183)   (183)    
Shares withheld for the withholding tax on vesting of restricted stock, Shares   (47,758)      
Unrealized loss on available-for-sale securities (54)     (54)  
Net Income (Loss) (34,867)       (34,867)
Ending balance at Mar. 31, 2025 $ 68,812 $ 6 $ 715,541 $ (7) $ (646,728)
Ending balance, Shares at Mar. 31, 2025   54,949,284